News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Week in Review: Zai Lab In-Licenses Two Sanofi Drug Candidates



8/18/2014 9:07:55 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ZAI Lab Limited, a novel drug development company located in Shanghai, broke out of stealth mode by announcing a major deal: the company has obtained global rights for two novel compounds from Sanofi (NYSE: SNY), both of which are potential treatments for chronic respiratory diseases (see story). ZAI is led by Dr. Samantha Du, who founded the company and serves as CEO. For ten years, Dr. Du was CEO of Hutchinson MediPharma, one of China’s very first innovative drug development companies. Since 2012, Dr. Du has been a Venture Partner at Sequoia Capital China.

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
Zai Lab
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES